Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Major Depressive Episode Associated With Bipolar II Disorder
Clinical Trial
NCT06429722Last updated: 12/4/2025
NMRA
Neumora Therapeutics, Inc.